Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitavastatin effects on lipids and carotid plaque in dyslipidemia
ChiCTR1800017776Phase 4Recruiting
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pitavastatin and ezetimibe in combined dyslipidaemia and hypercholesterolemia (3 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoints: LDL cholesterol and Carotid plaque. Started Aug 2018; status: recruiting.
02
Drugs
pitavastatinezetimibe
03
Conditions
combined dyslipidaemiahypercholesterolemia
Beyond the preview
Go deeper on ChiCTR1800017776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017776.